EDIT vs EIX
Editas Medicine Inc (EDIT) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
EDIT currently screens at market cap $375.2M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the EDIT and EIX stock pages for the full models.
Not investment advice.